Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,958 total articles
GCL Global Holdings announced that its subsidiary 4Divinity has obtained worldwide publishing and distribution rights for the action-stealth RPG "A Whisper of Fall: Jinyiwei", developed by Chengdu Cangmo. The game, set in China's Ming Dynasty, is planned for global release on PC and consoles in 2027. This deal enhances 4Divinity's portfolio with cu…
Exyn Technologies, a leader in autonomous mapping for GPS-denied environments, will present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference on June 23-24, 2026. CEO Brandon Torres Declet will deliver the presentation and participate in one-on-one investor meetings. The event highlights the company's innovative solutions for com…
Richtech Robotics Inc. announced the launch of a continuous livestream featuring its AI-powered humanoid robot, ADAM, enabling users worldwide to interact with the robot in real-time. Leveraging NVIDIA technology, this initiative positions Richtech Robotics as a pioneer in embodied AI and intelligent automation across sectors such as hospitality, a…
Lite Strategy, Inc., the first U.S. public company to adopt Litecoin as its primary treasury asset, has made a $1 million lead strategic investment in ZK Innovations Inc., developer of LitVM, the first zero-knowledge Layer 2 platform on Litecoin. This move aims to expand Litecoin's utility through smart contracts, DeFi, and tokenized assets, potent…
Quoin Pharmaceuticals has established a wholly-owned subsidiary in Japan to support the direct commercialization of its experimental drug QRX003 for Netherton Syndrome. This move follows Japan's granting of Orphan Drug Designation to QRX003 and aligns with the company's strategy to self-commercialize in its core markets: Japan, the U.S., and Wester…
MAIA Biotechnology has activated a third U.S. clinical site at Winship Cancer Institute of Emory University to enroll patients in its Phase 2 trial of ateganosine, a novel telomere-targeting agent for advanced non-small cell lung cancer (NSCLC). This expansion trial targets patients with resistant disease after checkpoint inhibitor and chemotherapy…
Nuwellis, Inc. showcased its Aquadex SmartFlow ultrafiltration technology at the 4th annual Critical Care Cardiology Education Summit at the University of Minnesota, providing hands-on training to over 280 physicians. This initiative aims to enhance cardiologists' and critical care specialists' ability to manage complex fluid overload cases in card…
LIXTE Biotechnology Holdings, Inc. announced it plans to acquire 100% of NOMAD Transportable Power Systems, a leader in mobile utility-grade battery energy storage systems (BESS). The acquisition is expected to close around July 1, 2026, with LIXTE providing a $6.5 million loan pre-closing to support NOMAD's order backlog and scaling efforts. Post-…
Fusemachines Inc. announced expanded connectivity of its Agentic AI for Talent Acquisition platform with over 30 applicant tracking systems, allowing recruiting agents to work directly within existing ATS platforms. This integration aims to improve recruiters' efficiency by leveraging AI-powered recruiting capabilities within familiar workflows, he…
Cabot Corporation (NYSE: CBT) has earned the EcoVadis Platinum rating for the sixth consecutive year, placing it in the top 1% of companies worldwide for environmental, social, and governance (ESG) practices. This year, Cabot improved its overall score by five points, its largest annual gain, with notable progress in ethics. The award highlights Ca…
Navigator Holdings Ltd., a leading global owner and operator of handysize liquefied gas carriers, announced it has arranged $205.8 million in financing for two newbuild vessels under construction in China. The financing includes a pre-delivery loan facility followed by a long-term Japanese Operating Lease with Call Option (JOLCO) sale and leaseback…
Nocera, Inc. announces a minority equity investment in CampaignPulse.ai, an AI-powered campaign intelligence platform designed to simulate and analyze audience reactions for optimizing messaging and strategies. The company also advances a partnership with Digital Innovations Group to integrate the IRMA AI Engine, aiming to build a diversified ecosy…
Aether Holdings, a fintech company traded on Nasdaq under ticker ATHR, has officially launched Alphid.ai, an advanced agentic AI platform now integrated with over 30 brokerage firms. This connectivity provides personalized portfolio analysis, market intelligence, and research to more than 400 million investors, transforming Alphid into a portfolio-…
BioRestorative Therapies, a Nasdaq-listed regenerative medicine company, announced the appointment of Zachary Smith as Vice President of its Biocosmeceuticals Division. Smith brings extensive commercial and sales leadership experience in aesthetics and regenerative health, aiming to accelerate commercial expansion and revenue growth in the company'…
Silo Pharma announced it has regained compliance with Nasdaq's minimum bid price rule, allowing continued trading on the Nasdaq Capital Market. The company is advancing its lead drug SPC-15 for PTSD towards a first-in-human clinical trial and developing its AI agents platform, QwikAgents. Silo Pharma focuses on novel therapeutics for stress-induced…
Our Bond, Inc. announced the renewal of a revolving credit facility providing access to up to $3 million in working capital under very favorable low-interest terms. This non-dilutive facility, supported by the founder and largest shareholder, enhances the company's financial flexibility without increasing immediate debt or interest expenses unless …
Scienture Holdings, Inc. announced expanded payor coverage for its oral suspension drug Arbli™, adding approximately 12.5 million covered lives across commercial, Medicare, and Medicaid channels in the U.S. The company is enhancing pharmacy network participation and distribution capabilities to increase patient access and prescription volume in the…
Byrna Technologies' CEO Conn Davis shares a detailed letter updating shareholders on his initial 100 days in leadership, focusing on expanding retail and e-commerce presence, shifting marketing from weapon-focused to safety-first messaging, enhancing customer education, and improving operational efficiency. The company aims to broaden its customer …
Prime Medicine announced that New Zealand's regulatory authority approved its clinical trial application for PM577a, the company's investigational Prime Editor therapy for Wilson Disease targeting the H1069Q ATP7B gene mutation. This clearance marks the first clinical authorization for Prime Medicine's in vivo Prime Editing treatment, enabling a gl…
BioCardia announces its focus for 2026 on submitting CardiAMP Cell Therapy for ischemic heart failure approval to Japan's PMDA, aiming for initial approval for a 20,000-patient subgroup. The company highlights its clinical trial enrollment progress in the US, innovative delivery platform partnerships, and plans for strategic collaborations around i…
RoboStrategy, Inc., a Nasdaq-listed closed-end fund focused on robotics and physical AI private companies, completed private placements raising approximately $28.9 million by issuing 797,434 shares at an average price of $36.28. The Fund aims to continue capital raises to invest in venture-backed robotics and embodied AI companies, bridging public …
Trio Petroleum Corp provides an update on its acquisition efforts focused primarily on oil and gas properties in Alberta and Saskatchewan, Canada. The company holds a strong cash position with no long-term debt, enabling financial flexibility to pursue acquisitions that meet strict technical and economic criteria. Trio has submitted multiple acquis…
Aterian, Inc. informed its stockholders about the mailing of proxy materials in advance of a Special Meeting on July 10, 2026. The meeting will cover approval of an $18 million asset sale of its marquee e-commerce brands to Trademark Global, and a $7 million preferred stock investment from strategic investor David E. Lazar. Proceeds from the asset …
Bionano Genomics announced a significant 67% increase in studies featuring its optical genome mapping technology at the 2026 European Society of Human Genetics conference compared to 2025. The expanded usage spans 17 countries across five global markets and covers diverse genetic research areas such as rare disorders, cancers, and cardiovascular ge…
ZenaTech, Inc. announced the unveiling of Zoo Office™, a unified AI-powered productivity platform designed to unify and enhance its enterprise SaaS ecosystem and capitalize on the fast-growing Agentic AI market. The platform aims to automate workflows, enhance decision-making, and reduce software sprawl by providing an intelligent, connected busine…
